# Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity

> **NCT05741606** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tabriz University of Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** Sodium pentaborate pentahydrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05741606
- **Lead sponsor:** Tabriz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-21
- **Primary completion:** 2024-03-20
- **Final completion:** 2025-03-21
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741606, "Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05741606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*